期刊文献+

液基细胞学联合初善仪检测在宫颈癌筛查中的应用 被引量:2

Value of TruScreen combined with Thinprep cytology test in screening of cervical lesions
下载PDF
导出
摘要 目的:探讨液基细胞学(TCT)与初善仪(TS)在宫颈病变筛查中的联合应用价值。方法选择2013年12月~2014年11月就诊于解放军总医院妇科门诊阴道镜室的患者218例,所有患者均给予TCT及TS检查,并根据TCT及TS检查结果进行分组,结合病理学结果分析两种检测方法细胞学诊断价值的差异。结果TCT结果显示,218例患者中,不能明确意义的非典型鳞状细胞(ASC-US)76例,非典型鳞状细胞不除上皮内高度病变(ASC-H)43例,低度鳞状上皮内病变(LSIL)58例,高度鳞状上皮内病变(HSIL)41例;TS检测异常者94例。病理结果正常者106例,LSIL/CIN 141例,HSIL/CIN 2~371例。病理结果正常患者中,细胞学ASC-H与LSIL的检出率分别为53.5%和56.9%;低级别病变患者中,ASC-US和LSIL的检出率显著高于ASC-H及HSIL组(P=0.005);高级别病变患者中,ASC-H及HSIL的检出率显著高于ASC-US和LSIL(P=0.004)。经TS分层后,TS阴性而病理结果正常的患者中,TCT各组的检出率均提高;TS阳性而病理低级别病变患者中,ASC-US与LSIL的检出率升高,ASC-H与HSIL呈下降趋势,高级别病变患者中,TBS分级四组的检出率均升高。结论联合应用TS可以减少阴道镜门诊的过度转诊并能够更灵敏地发现高级别病变患者。 Objective To investigate the value of TruScreen (TS) combined with Thinprep cytology test in screening of cervical lesions. Methods 218 patients from December 2013 to November 2014 in Outpatient Vaginoscopy Room of PLA General Hospital, all patients were given the detection of TCT and TS, they were divided into different group ac-cording the detection results of TCT and TS, and diagnostic value of TCT and TS were evaluated by pathology result as a golden standard. Results The results of TCT showed that, there were 76 cases of ASC-US, 43 cases of ASC-H, 58 cases of LSIL and 41 cases of HSIL in total of 218 patients; TS showed that 94 cases were abnormal. Pathological re-sults showed that, 41 cases of LSIL/CIN 1 and 71 cases of HSIL/CIN 2-3, other 106 cases were normal. Among cases with normal pathological findings, the positive rate of ASCH and LSIL in cytology was 53.5% and 56.9% respectively. Patients with low grade lesions, the detection rate of ASC-US and LSIL was significantly higher than that of ASC-H and HSIL (P= 0.005). In cases of high-grade lesions, the positive rate of ASC-H and HSIL was significantly higher than those of ASC-US and LSIL (P=0.004). After stratification by TS, the detection rate of TCT in each group was im-proved in cases with negative TS findings and normal pathological results. The positive rate of ASC-US and LSIL group increased in cases with positive TS findings and low grade lesion by pathology, ASC-H and HSIL groups composed of a downward trend. Positive rate of 4 groups named by TBS increased in cases with high-grade lesion. Conclusion Combined application of TS can reduce the excessive re-ferral to colposcopy clinics and detect patients with the high grade lesion more sensitively.
出处 《中国医药导报》 CAS 2015年第18期66-70,74,共6页 China Medical Herald
基金 解放军总医院临床科研扶持基金项目(2013FCZHCG-1005)
关键词 宫颈病变 筛查 液基细胞学 初善仪 Cervical lesion Screening Thinprep cytol-ogy test TruScreen
  • 相关文献

参考文献37

  • 1Renshaw AS,Young NA, Birdsong GG,et al. Comparison of pedormance of conventional and Thinprep gynecologic preparation in the college of American Pathologists Gyneco- logic Cytology Program [J]. Arch Pathol Lab-Med,2004,128 (1):17. 被引量:1
  • 2National Comprehensive Cancer Network.NCCN clinical practice guidelines in Oneology :cervical cancer(2014.V1) [EB/OL]. http://guide.medlive.cn/guideline/5499. 被引量:1
  • 3Smith JH. Bethesda 2001 [J]. Cytopathology,2002,13( 1 ) : 4-10. 被引量:1
  • 4Darragh TM,Colgan TJ,Thomas Cox J,et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions:background and consensus recommendations from the college of american pathologists and the american society for colposcopy and cervical pathology [J]. Int J Gynecol Pathol, 2013,32( 1 ) : 76-115. 被引量:1
  • 5Ferlay J,Shin HR,Bray F,et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008 [J]. Cancer, 2010,127(12) : 2893-2917. 被引量:1
  • 6卞美璐.WHO(2006年)宫颈癌综合防治实践指南简介[J].中国实用妇科与产科杂志,2007,23(7):557-560. 被引量:106
  • 7IARC Globocan. Cancer Fact Sheet:Cervical Cancer Esti- mated Incidence,Mortality and Prevalence Worldwide in 2012 [EB/OL]. http://globocatr Iar frIPages/fact_sheetscan- cer. aspxdescriptive epidemiology. 被引量:1
  • 8胡媛华,夏琴,熊员焕.三种宫颈癌联合筛查方案的对比研究[J].中国妇幼保健,2012,27(26):4039-4042. 被引量:9
  • 9陈蔚,徐军,杨慧娟.TCT和HPV在不同年龄段宫颈病变筛查中的价值[J].中国医药指南,2012,10(27):32-33. 被引量:8
  • 10Wingo PA,Cardinez CJ,Landis SH,et al. Long -term trends in cancer mortality in the United States, 1930- 1998 [J]. Cancer,2003,97(12 Suppl) :3133-3275. 被引量:1

二级参考文献54

  • 1吕卫国,谢幸.宫颈癌的筛查[J].中国实用妇科与产科杂志,2006,22(1):8-9. 被引量:95
  • 2李荣.TCT检测在宫颈癌筛查中的临床应用[J].江苏医药,2007,33(5):516-517. 被引量:26
  • 3卞美璐.WHO(2006年)宫颈癌综合防治实践指南简介[J].中国实用妇科与产科杂志,2007,23(7):557-560. 被引量:106
  • 4魏丽惠.应高度关注子宫颈病变的筛查[J].中国医刊,2007,42(8):2-5. 被引量:27
  • 5Cuzick J, Arbyn MM, Sankaranarayanan R et al. Overview of human papillomavirus - based and other novel options for cervi- cal cancer screening in developed and developing countries [J] .Vaccine, 2008, 19:26. 被引量:1
  • 6Wright TC Jr. Cervical cancer screening in the 21st century: is it time to retire the PAP smear [J] . Clin Obstet Gynecol, 2007, 50 (2): 313. 被引量:1
  • 7Celik C, Gezginc K, Toy H et al. A comparison of liquid based cytology with conventional cytology [J] . Int J Gynaecol Obstet, 2008, 100:163. 被引量:1
  • 8Sabuhi Qureshi, Vinta Das, Fatima Zahra. Evaluation of visu-al inspection with acetic acid and Lugol's iodine as cervical cancer screening tools in a low - resource setting [J]. Tropical Doctor, 2010, 40:9. 被引量:1
  • 9Goldie SJ, Kim JJ, Wright TC. Cost - effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more [ J ]. Obstet Gynecol, 2004, 103 : 617. 被引量:1
  • 10Sankaranarayanan R, Esmy PO, Rajkumar R et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster randomised trial [ J] . Lancet, 2007, 370 (9585): 398. 被引量:1

共引文献152

同被引文献23

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部